ArticlePloS one2015

Correction: The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.